Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by lnvestor198on Sep 06, 2016 2:39am
158 Views
Post# 25208991

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Takeover/Way Undervalued

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Takeover/Way Undervalued
Hockeyz wrote: https://seekingalpha.com/article/3999508-concordia-q2-review-series-misfortunes-mismanagement?li_source=LI&li_medium=liftigniter-widget
.

This article that you posted is from a  LONG?  
Are you kidding me?  
This sounds like Q3  will be a bigger disaster.

For investors who have lost confidence in this management and stock, Q3 will very likely be ugly. North American segment will post worst numbers, and more write-down is likely to happen. Concordia has been mismanaged and is saddled with debt, only performance can save it from here. Investors are frustrated with the performance and short sellers have succeeded in this case. Management need to redeem itself by realign all aspects of the business towards deleveraging and operational results. I would not recommend investors buying this name purely due to its cheap valuation.

Disclosure: I am/we are long CXRX.

 
<< Previous
Bullboard Posts
Next >>